Kidney health in chronic myeloid leukemia
Part of Blood & lymphatic, Cancer, Kidney & urinary clinical trials.
This study looks at how chronic myeloid leukemia (CML) might affect the kidneys. It is for people with a CML diagnosis (confirmed by biopsy) who do not have diabetes or other kidney diseases that started before their leukemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic myeloid leukemia (CML) by a biopsy.
- You had a complete blood count (CBC) test done as part of your diagnosis.
- You did not have chronic kidney disease (CKD) before your CML diagnosis.
- You do not have diabetes.
- Your kidney problems are not caused by other conditions like polycystic kidney disease, kidney stones, or chronic pyelonephritis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This follow-up study looks at people with chronic myeloid leukemia (CML) who have been in deep remission and may be able to stay off treatment. It checks how long remission lasts and how their leukemia tests behave over time.
This study looks at how chronic myeloid leukemia (CML) affects your daily life and how care is organized in Lombardy hospitals. Researchers want to learn from your experiences to improve care for everyone with CML.
This research study examines blood cells from patients with chronic myelomonocytic leukemia (CMML), a rare blood cancer, to better understand how the disease develops and progresses. By studying your blood cells, researchers hope to learn more about what causes CMML and how to treat it better.
This study looks at how certain CML treatments called tyrosine kinase inhibitors affect blood sugar and cholesterol levels in people with chronic myeloid leukemia. It may help understand if these drugs change metabolism.
This study looks at the health characteristics, other illnesses, and treatment patterns of people with chronic myeloid leukemia (CML) in Kuwait. It aims to help doctors better understand how CML is managed and improve care.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
Hear when a new Chronic Myeloid Leukemia in Remission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.